Contextuality and Nonlocality in Decaying Multipartite Systems

Everyday experience supports the existence of physical properties independent of observation in strong contrast to the predictions of quantum theory. In particular, existence of physical properties that are independent of the measurement context is prohibited for certain quantum systems. This property is known as contextuality. This paper studies whether the process of decay in space-time generally destroys the ability of revealing contextuality. We find that in the most general situation the decay property does not diminish this ability. However, applying certain constraints due to the space-time structure either on the time evolution of the decaying system or on the measurement procedure, the criteria revealing contextuality become inherently dependent on the decay property or an impossibility. In particular, we derive how the context-revealing setup known as Bell's nonlocality tests changes for decaying quantum systems. Our findings illustrate the interdependence between hidden and local hidden parameter theories and the role of time.Comment: 5 pages, 2 figure

Vulnerability of "A novel protocol-authentication algorithm ruling out a man-in-the-middle attack in Quantum Cryptography"

In this paper we review and comment on "A novel protocol-authentication algorithm ruling out a man-in-the-middle attack in quantum cryptography", [M. Peev et al., Int. J. Quant. Inform., 3, 225, (2005)]. In particular, we point out that the proposed primitive is not secure when used in a generic protocol, and needs additional authenticating properties of the surrounding quantum-cryptographic protocol.Comment: 6 page

Rheumatoid arthritis, gold therapy, contact allergy and blood cytokines

OBJECTIVE: To study the clinical and biochemical effects of a low starting dose for gold therapy in rheumatoid arthritis patients with a contact allergy to gold. METHODS: Serum cytokines were assayed before and 24 h after the first injection of gold sodium thiomalate (GSTM). RESULTS: Contact allergy to gold was found in 4 of 19 patients. Compared to gold-negative patients (starting dose: 10 mg GSTM), there was a larger increase in serum TNFalpha (p < 0.05), sTNF-R1 (NS), and IL-1 ra (p < 0.05) in gold-allergic patients. CONCLUSIONS: Cytokines are released in blood by GSTM in RA patients with gold allergy. To minimize the risk of acute adverse reactions the starting dose of GSTM should be lowered to 5 mg. Alternatively, patients should be patch-tested before gold therapy; in test-positive cases, 5 mg is recommended as the first dose